◀ Back to TFAP2A
IRF6 — TFAP2A
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Zhou et al., Toxicol Appl Pharmacol 2003
(Inflammation) :
Antibody supershift EMSA and Western blot analysis confirmed that increased binding of these factors correlated with
LPS induced increases in nuclear concentrations of AP-1 ( c-Jun, phosphorylated c-Jun, Jun D, and Jun B ), C/EBPbeta, NF-kappaB ( p50, p65, and c-Rel ), CREB ( CREB-1, CREB-2, and ATF-2 ), and
AP-2alpha proteins
Xie et al., Cell Physiol Biochem 2011
:
Furthermore, DBZ suppressed LPS activated macrophages lipid accumulation, partly due to inhibiting the expression of
LPS induced
aP2 and ADRP in macrophges